These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10327307)

  • 1. Treatment of autoimmune blistering diseases.
    Levy M; Rico MJ
    Dermatol Clin; 1999 Apr; 17(2):431-40, x. PubMed ID: 10327307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating immunobullous diseases: an update.
    Reynaert S; Black MM
    Dermatol Nurs; 2004 Feb; 16(1):29-34, 70. PubMed ID: 15022502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of autoimmune blistering diseases.
    Rico MJ
    Cutis; 1993 Dec; 52(6):357-61. PubMed ID: 8293677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases.
    Ishii N; Hashimoto T; Zillikens D; Ludwig RJ
    Clin Rev Allergy Immunol; 2010 Apr; 38(2-3):186-95. PubMed ID: 19557317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment of autoimmune blistering diseases.
    Kasperkiewicz M; Schmidt E
    Curr Drug Discov Technol; 2009 Dec; 6(4):270-80. PubMed ID: 20025595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies.
    Schiavo AL; Puca RV; Ruocco V; Ruocco E
    Clin Dermatol; 2010; 28(3):337-43. PubMed ID: 20541689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Update of Autoimmune Blistering Diseases.
    Kridin K; Ahn C; Huang WC; Ansari A; Sami N
    Dermatol Clin; 2019 Apr; 37(2):215-228. PubMed ID: 30850044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune bullous diseases: diagnosis and management.
    McCuin JB; Hanlon T; Mutasim DF
    Dermatol Nurs; 2006 Feb; 18(1):20-5. PubMed ID: 16550892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in pemphigus therapy.
    Prajapati V; Mydlarski PR
    Skin Therapy Lett; 2008 Apr; 13(3):4-7. PubMed ID: 18506357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the treatment of autoimmune mucocutaneous blistering diseases.
    Ahmed AR
    Int J Periodontics Restorative Dent; 2007 Aug; 27(4):309-10. PubMed ID: 17726986
    [No Abstract]   [Full Text] [Related]  

  • 11. [Practical management of the most common autoimmune bullous diseases].
    Suárez-Fernández R; España-Alonso A; Herrero-González JE; Mascaró-Galy JM
    Actas Dermosifiliogr; 2008; 99(6):441-55. PubMed ID: 18558052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update.
    Czernik A; Toosi S; Bystryn JC; Grando SA
    Autoimmunity; 2012 Feb; 45(1):111-8. PubMed ID: 21923613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of acquired bullous skin diseases.
    Fine JD
    N Engl J Med; 1995 Nov; 333(22):1475-84. PubMed ID: 7477149
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycophenolate mofetil for the management of autoimmune bullous diseases.
    Eskin-Schwartz M; David M; Mimouni D
    Immunol Allergy Clin North Am; 2012 May; 32(2):309-15, vii. PubMed ID: 22560143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice and Educational Gaps in Blistering Disease.
    Ehsani-Chimeh N; Marinkovich MP
    Dermatol Clin; 2016 Jul; 34(3):251-6. PubMed ID: 27363880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autoimmune blistering skin diseases: recent advances].
    Joly P
    Presse Med; 2010 Oct; 39(10):1040-1. PubMed ID: 20692800
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of intravenous immunoglobulin in autoimmune bullous diseases.
    Chee SN; Murrell DF
    Immunol Allergy Clin North Am; 2012 May; 32(2):323-30, viii. PubMed ID: 22560145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of autoimmune bullous diseases: pharmacology and therapeutics.
    Mutasim DF
    J Am Acad Dermatol; 2004 Dec; 51(6):859-77; quiz 878-80. PubMed ID: 15583576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil for the management of autoimmune bullous diseases.
    Eskin-Schwartz M; David M; Mimouni D
    Dermatol Clin; 2011 Oct; 29(4):555-9. PubMed ID: 21924997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimizing therapy in patients with severe autoimmune blistering skin diseases].
    Schmidt E
    Hautarzt; 2009 Aug; 60(8):633-40. PubMed ID: 19536513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.